european network for adrenal tumors

steering committee

Chair of the Executive Committee

Martin Fassnacht, MD
Head of the Division of Endocrinology and Diabetes
Department of Internal Medicine I
University Hospital Würzburg
Oberdürrbacherstr. 6
Würzburg, Germany

Martin Fassnacht is Professor of Internal Medicine and Endocrinology at the University of Würzburg. He is head of the Division of Endocrinology and Diabetes at the University Hospital Würzburg. The main interest of his clinical and translational research group is endocrine tumors with a special focus on adrenal tumors. He run(s) several clinical trials for patients with adrenocortical carcinoma and malignant pheochromocytoma and his translational group is adrenocortical tumorigenesis and drug targets for adrenocortical carcinoma.

Period in office: 2016-2022

Secretary

Henri Timmers, MD, PhD
Division of Endocrinology
Department of Internal Medicine
Radboud University Medical Centre
Geert Grooteplein Zuid 8
Radboud, The Netherlands

Henri Timmers (1971), M.D./Ph.D., is clinical endocrinologist and assistant professor at the Department of Medicine, section of Endocrinology, Radboud University Medical Centre, in Nijmegen, the Netherlands. He is head of the Radboud Adrenal Center and member of the steering committees of ENS@T and the international Pheochromocytoma and Paraganglioma Research Support Organization (PRESSOR). His principle clinical and scientific focus is on adrenal diseases, especially pheochromocytoma and paraganglioma.

Period in office: 2011-2017

Treasurer

Anne-Paule Gimenez-Roqueplo, MD, PhD
INSERM UMR 970
or/ Service de Génétique
Hôpital européen Georges Pompidou
rue Leblanc
Paris, France

Professor Anne-Paule Gimenez-Roqueplo (MD, specialized in Endocrinology, PhD in Genetics) is Full Professor in Genetics at Paris Descartes University. She is responsible of the Oncogenetic activity (molecular tests and multidisciplinary counsultation) in the Genetics department of Hôpital Européen Georges Pompidou (Paris, France). Her main interests are benign and malignant pheochromocytomas and paragangliomas (PPGL). She is the Director of an academic research team entitled “Pheochromocytomas and Paragangliomas, from Genetics to Molecular Targeted Therapies” within the INSERM Unit 970 at the Paris Cardiovascular Center at HEGP (PARCC@HEGP), Paris, France (http://parcc.inserm.fr/). She is the coordinator of PGL.R, the National French registry for SDHx-related paragangliomas.

Period in office: 2013-2019

Other members of the Steering Committee

Mercedes Robledo, PhD
Hereditary Endocrine Cancer, Group Leader
Human Cancer Genetics Programme
Spanish National Cancer Centre (CNIO)
C/ Melchor Fernández Almagro 3
Madrid, Spain

Mercedes Robledo is the head of the Hereditary Endocrine Cancer Group, in the Human Genetics Cancer Program at the Spanish National Cancer Center (CNIO), Madrid, Spain. Her Group is interested in identifying high and low genetic risk factors involved in pheochromocytoma and thyroid cancer susceptibility. To this end, we analyse tumour samples and look for differences between genomic features according to the different individual genetic backgrounds. Such comprehensive characterisation allows us, not only to define diagnostic and prognostic markers associated with primary mutations, but also to pinpoint specific altered pathways that can lead to the identification of future therapeutic targets.

Period in office: 2015-2021

Tracy Ann Williams, BSc, PhD
Division of Internal Medicine and Hypertension
Department of Medical Sciences
University of Torino
Via Giuseppe Verdi 8
Torino, Italy

Dr. Williams heads the laboratory of genetics and molecular biology of hypertension in the Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, Italy. She is visiting research scientist at the Medizinische Klinik and Poliklinik IV, Ludwig-Maximilians University in Munich. Her main interests are monogenic forms of hypertension and disorders of aldosterone production centering on aldosterone-producing adenomas.

Period in office: 2015-2021

Giuseppe Opocher, MD
Familial Cancer Clinic and Oncoendocrinology
Veneto Institute of Oncology
University of Padova
Via Gattamelata 64
Padova, Veneto, Italy

Period in office: 2014-2020

Former Members of the Steering Committe

Felix Beuschlein, MD
Endocrine Research Unit
Medizinische Klinik und Poliklinik IV
University Hospital Munich
Ziemssenstr. 1
Munich, Germany

Felix Beuschlein is Professor of Internal Medicine/Endocrinology, Head of the Endocrine Research Unit and runs the Endocrine Outpatient Clinic at the University Hospital in Munich. His main scientific interest pertain to all fields of adrenal research including adrenocortical carcinoma, primary aldosteronism, Cushing’s syndrome and pheochromocytoma. He has served as the chairman of ENSAT between 2008 and 2016 and has led an FP7 funded consortium on adrenal tumors (ENSAT-CANCER).

Former Chair of the Executive Committee. Period in office: 2009-2016

Jérôme Bertherat, MD, PhD
Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre National de la Recherche Scientifique (CNRS)
Institut Cochin, Université Paris-Descartes
22, rue Mechain
Paris, France

Period in office: 2009-2016

Wiebke Arlt, MD, DSc., FRCP, FMedSci
Institute of Metabolism and Systems Research (IMSR)
University of Birmingham
& Centre for Endocrinology, Diabetes and Metabolism (CEDAM)
Birmingham Health Partners
Birmingham, UK

Professor Wiebke Arlt is William Withering Chair of Medicine and Director of the Institute of Metabolism and Systems Research at the University of Birmingham, UK. She leads a multi-disciplinary research group focussing on steroid endocrinology in the context of adrenal and gonadal disorders. She is a Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham, where she serves as the Lead of the Adrenal Tumour Specialist Service. Her main interests are adrenal incidentaloma, adrenocortical carcinoma and adrenal steroid excess syndromes.

Period in office: 2009-2016

Massimo Terzolo, MD
Head of Department of Internal Medicine I
University of Torino
Regione Gonzole 10
Torino, Italy

Period in office: 2009-2014

Massimo Mannelli, MD

Department of Experimental and Clinical Biomedical Sciences

University of Florence

Florence, Italy

Period in office: 2009-2011

Founding Steering Committe Members (2002-2009)

Bruno Allolio, Würzburg, Germany

Xavier-Yves Bertagna, Paris, France

Massimo Manelli, Florence, Italy

Franco Mantero, Padua, Italy

Pierre-Francois Plouin, Paris, France

Paul M. Stewart, Leeds, UK